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Headache and its Association with ADHD/ADD and Stimulant Medication 
For years, the experience of headache and migraine have been studied to determine what 
causes or perpetuates headache in terms of their frequency, duration, and intensity. Research has 
indicated that there is no simple answer to this question; depending on the individual, an array of 
different factors can contribute to or worsen the experience of headache. However, one 
phenomenon has become clear through years of research: headache is perpetuated by disruption 
to lifestyle. For individuals who experience headache, the frequency, duration, and severity of 
headache can worsen when the individual’s lifestyle behaviors like sleep habits, eating habits, 
level of stress, physical activity, etc. are dysregulated. A sleep disturbance, which could be too 
much sleep, too little sleep, inappropriate timing of sleep, or inappropriate sleep behavior can be 
a trigger for headache (Dosi 2015). Likewise, irregularity in intake of meals, which can be due to 
skipping a meal (often breakfast), altering mealtimes, or eating frequently between meals can be 
a trigger for headache (Moschiano 2012). 
Individuals with Attention Deficit Hyperactivity Disorder (ADHD) are prone to 
dysregulation in lifestyle behaviors. Attention Deficit Hyperactivity Disorder (ADHD) and 
Attention Deficit Disorder (ADD) are defined as causing symptoms of hyperactivity, 
impulsivity, and/or inattention in individuals affected by it (Frampton 2018). Individuals with 
ADHD/ADD are more likely to struggle with maintaining a regulated lifestyle as ADHD/ADD 
cause individuals to be more forgetful, more impulsive, and lack control over their own thoughts 
and attentiveness. A prior research study conducted by the European Child & Adolescence 
Psychiatry investigated sleep, chronotype, and sleep hygiene in children with ADHD and autism 
disorder (van der Heijden 2018). It found that children with ADHD had significantly later sleep 
onset and shorter sleep duration than the control group—children without ADHD (van der 
HEADACHE, ADHD/ADD, AND STIMULANT MEDICATION 3 
 
Heijden 2018). No research could be found examining the relationship between skipping meals 
and having ADHD specifically.  
Individuals with ADHD/ADD may be more likely to experience headache due to a more 
dysregulated lifestyle. A prior study conducted by the K.G. Jebsen Centre for Research on 
Neuropsychiatric Disorder at the University of Bergen in Norway examined the relationship 
between ADHD symptoms and migraines as well as other comorbid conditions (Fasmer 2011). 
In this study, the researchers found that adult patients with persistent ADHD had more frequent 
migraines as compared to the control group (Fasmer 2011). In a systematic review and meta-
analysis of literature conducted by the Neuropsychiatry Program at the University of Texas 
Health Science Center, researchers analyzed the relationship between having ADHD and 
experiencing migraine or tension-type headache (Salem 2018). Their results showed a significant 
association between migraines and ADHD yet no definitive association between headache in 
general and ADHD. More research needs to be conducted to further understand whether 
headache in general are worsened or triggered by having ADHD.  
Recreational usage of stimulant drugs such as Adderall and Vyvanse, which are designed 
specifically to treat symptoms of ADHD and ADD, is rampant on many university and college 
campuses. Individuals who take stimulant drugs may also be more likely to experience headache. 
Stimulant drugs used to treat ADHD/ADD, such as Adderall, Vyvanse, and the generic forms of 
each, are known to have the following side effects: loss of appetite, insomnia, irritability, weight 
reduction, and headache (Frampton 2018). Not only is headache a potential side effect of these 
stimulant drugs, disruption of many lifestyle factors which have been linked with triggering 
headache are also side effects. This begs the question: is headache experience worsened and or 
triggered because of having ADHD/ADD or because of taking stimulant drugs to treat 
HEADACHE, ADHD/ADD, AND STIMULANT MEDICATION 4 
 
ADHD/ADD? No research has been conducted to explicitly examine the potential relationship 
between stimulant drug usage and headache experience, thus we propose to lay the foundation to 
fill this gap in knowledge. 
We have chosen college undergraduate students as our test sample because of the 
rampant recreational Adderall and Vyvanse usage across many college and university campuses 
in the United States. College-aged individuals with ADHD and/or ADD have not been 
represented in the past literature examining ADHD/ADD and headache experience. Some 
lifestyle factors are uniquely characteristic of a college-aged population: increased stress, 
dysregulated mealtimes, dysregulated sleeping and waking times, and usage of drugs to enhance 
school performance. Because college-aged individuals are often living on their own for the first 
time without a parent or guardian present to regulate their eating or sleeping habits, they are 
more likely to have dysregulated lifestyle behaviors than other age groups of adults. The limited 
research conducted on understanding the association between ADHD/ADD and headache has 
either been conducted on children or adults ages 18 to 65. No research has focused specifically 
on the young adult college-aged population alone. The lifestyle of an 18 year old is vastly 
different than that of a 65 year old so research needs to be conducted specifically on a more 
limited aged group to fully understand whether a relationship exists.  
Due to the vast gaps in research conducted on this topic there is a clear need for more 
research. While some studies have been conducted to investigate the relationship between 
headache and ADHD/ADD or headache and stimulant medication, or ADHD/ADD and stimulant 
medication, almost no research has been conducted to understand the relationship of all three, let 
alone for undergraduate college students. In this study we aim to explore the potential combined 
and independent impacts that having ADHD/ADD and taking stimulant drugs have on disrupting 
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one’s lifestyle and examine whether dysregulated lifestyle factors contribute to one’s headache 
experience. We hypothesize that those with or without ADHD/ADD that take stimulant drugs 
will show a pattern of dysregulated lifestyle, meaning inconsistent eating and sleeping habits. 
Conversely, we expect that those with or without ADHD/ADD who do not take stimulant drugs 
will not show a pattern of dysregulated lifestyle, meaning they will have consistent eating and 
sleeping habits for what is expected of a population of college students. Therefore, we predict 
that those who take stimulant drugs with or without ADHD/ADD will have a greater degree of 
dysregulated lifestyle than those who do not take stimulant drugs with or without ADHD/ADD. 
We postulate that there will be similar patterns of headache frequency, duration, and intensity 
(no statistically significant difference) between the two groups of individuals who take stimulant 
drugs: those with ADHD/ADD and those without ADHD/ADD. Likewise, we theorize that there 
will be similar patterns of headache frequency, duration, and intensity (no statistically significant 
difference) between the two groups of individuals who do not take stimulant drugs: those with 
ADHD/ADD and those without ADHD/ADD. Finally, we speculate that those with ADHD/ADD 
who take stimulant drugs will have a greater frequency, duration, and intensity of headache 
experience than those with ADHD/ADD who do not take stimulant drugs. 
In this study we will examine the potential relationship between having ADHD/ADD and 
experiencing more frequent, longer, and/or more severe headache episodes. To fully understand 
our results, we plan on exploring whether ADHD/ADD plays a role in the dysregulation of one’s 
lifestyle behaviors. We will also investigate the potential relationship between taking stimulant 
drugs to either treat ADHD/ADD or recreationally and experiencing more frequent, longer, 
and/or more severe headache episodes. Similarly, we will examine whether stimulant drug usage 
plays a role in the dysregulation of one’s lifestyle behaviors. 
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Methods 
 In our cross sectional control study, participants were categorized into one of four groups 
based on whether or not they have ADHD/ADD and whether or not they take stimulant drugs, 
such as Adderall and Vyvanse. The four groups are as follows: those that have ADHD/ADD and 
take stimulants, those that have ADHD/ADD and do not take stimulants, those that do not have 
ADHD/ADD and take stimulants, and the control group, those that do not have ADHD/ADD and 
do not take stimulants. Through the computer algorithm in RedCap, we randomly assigned a 
record identification number to each participant so that each participants answers to the survey 
could not be linked back to them. The primary independent variable is the categorical group, 
which is based on each participant’s answers to the following questions: do you have 
ADHD/ADD and do you take stimulants such as Adderall or Vyvanse. The dependent variables 
for measuring degree of dysregulation of lifestyle factors include the consistency of eating and 
sleeping habits. The dependent variables for measuring headache experience includes the 
frequency, duration, and severity of headache. This study has been approved by the University of 
Connecticut IRB. All participants in the study have given their consent to participate in the study 
by signing informed consent forms. 
Participants 
 To be eligible to participate in the study, UConn undergraduate students must be between 
the ages of 18 and 40 and experience on average at least 2 diagnosed or undiagnosed headaches 
or migraines a month. Sampling methods involved sending out email blasts, which included a 
link to the survey, in the UConn Undergraduate Student Daily Digest, UConn Health Lifeline, 
CAHNR/RHSA Student Digest, Sociology Undergrad Digest, Neag School Student News, New 
to Storrs, News for International Students & Scholars, & Philosophy Undergrad Digest; the 
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investigator making announcements at the beginning of several classes; and professors within 
CAHNR (College of Agriculture Health and Natural Resources) making announcements to their 
students. All sampling methods were geared towards reaching a wide breadth of UConn students 
to recruit a random sample of UConn undergraduates. Two hundred thirty-one (n = 231) students 
responded to the recruitment efforts, of which 12 did not complete the survey and 42 did not 
meet the eligibility requirements. The remaining 177 students participated in the study. 
Participants were not compensated for participation in the study.  
Survey 
 Participants engaged in an electronic 10-minute survey over RedCap which asked for 
their demographics, eligibility information, presence or absence of ADHD/ADD diagnosis, 
stimulant medication usage, headache experience, and lifestyle behaviors. The survey consisted 
of a total of 20 questions; however, participants were asked a total of 15 or 19 questions 
depending on their responses to questions on stimulant drug use. Participants were required to 
answer every question, but for every question participants could select the answer option “I do 
not wish to disclose” if they were not comfortable giving an answer. 
The survey included 4 demographic questions with drop down answer options that did 
not ask participants for any identifiable information. The following demographic information 
was collected gender, age, race, and year in college. Participants were asked one yes or no 
question regarding their eligibility—do you experience at least 2 headaches or migraines a 
month? (does not have to be diagnosed). The eligibility question was programmed with a stop 
function that triggered the survey to end when a particular answer was selected. If a participant 
answered “no,” then a window would pop up stating “you have selected an option that triggers 
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this survey to end right now” and prompting them to click either “end the survey now” or 
“continue survey and undo last response.” 
All participants were asked if they have been diagnosed with ADHD or ADD, to which 
they could answer “yes” or “no”. Participants were either asked 1 or 5 questions with drop down 
answer options regarding their usage of stimulant medications. All participants were asked if 
they take stimulant ADHD/ADD medications, recreationally or as prescribed, to which they 
could answer “no”, “yes, I take Adderall”, or “yes, I take Vyvanse.” Participants that answered 
no or I do not wish to disclose, bypassed the 4 remaining questions regarding stimulants. Those 
that answered yes, were ask 3 of the 4 possible remaining questions regarding stimulants. The 
question that followed asked participants what dosage in mg they took of either Adderall or 
Vyvanse. Because the dosage increments of Adderall and Vyvanse differ considerably, there are 
two separate dosage questions: one for those that answered “yes, I take Adderall” to the previous 
question and one for those that answered “yes, I take Vyvanse.” Next, participants were asked 
about the consistency with which they take stimulants. Specifically, we asked if the dosage they 
take varies, the number of days per week they take stimulants, and the typical time of day they 
take stimulants. 
Participants were categorized into one of four groups based on their answers to the 
following two questions: “do you have diagnosed ADHD or ADD?” and “do you take stimulant 
ADHD/ADD medications? (prescribed or recreationally).” The four groups—ADHD/ADD 
stimulants, ADHD/ADD no stimulants, no ADHD/ADD stimulants, and no ADHD/ADD no 
stimulants—will be compared based on three measures: headache experience, sleeping habits, 
and eating habits.  




Participants were asked 3 questions with drop down answer options regarding their headache 
experience. They were asked the number of headache episodes they typically have in a month 
(answer options included values 1-11, 12 or more but not daily, and daily), the length of time 
their headache typically lasts (answer options included 1 hour - 16 hours, 1 day - 3 days, and 
longer than 3 days), and how painful their headache is (answer options included no pain, mild 
pain, moderate pain, and severe pain). 
Sleeping Habits 
Participants were asked 4 questions with drop down answer options regarding their 
sleeping habits. They were asked the average number of hours they sleep each night (answer 
options included less than 3, values 4-13), if they ever have sleepless nights (which we defined 
as not sleeping at all or sleeping less than a total of 2 hours), the number of times per week that 
their bedtime varies by more than an hour (answer options included less than once a week, once 
a week, 2-3 times, 4-5 times, and 6-7 times), and the number of times per week that their waking 
time varies by more than an hour (answer options were the same as the last question).  
Eating Habits 
Participants were asked 1 question with drop down answer options regarding their eating 
habits. They were asked the number of days per week that they skip a meal, to which they could 
answer values zero through seven. 
  
HEADACHE, ADHD/ADD, AND STIMULANT MEDICATION 10 
 
Results 
 After survey data was collected and participants were categorized into one of four groups. 
There were 13 participants in the ADHD/ADD stimulants group, 8 participants in the 
ADHD/ADD no stimulants group, 3 participants in the no ADHD/ADD stimulants group, and 
153 participants in the no ADHD/ADD no stimulants group. Due to the limited number of 
participants in the no ADHD/ADD stimulants group, the two no ADHD/ADD groups were 
collapsed into one group. Ultimately, there were three groups—ADHD/ADD Stimulants, 
ADHD/ADD No Stimulants, and No ADHD/ADD—to analyze and compare based on the three 
sets of measures.  
Descriptive Statistics 
Descriptive statistics on the whole participant sample and each group independently for 
each of the demographic, headache experience, sleeping habit, eating habit variables are included 
in Table 1. For this college sample, the mean headache frequency was 4.28 (SD = 2.64), the 
mean hours of sleep per night was 7.14 (SD = 1.17) and 59.32% of participants skip meals less 
than four days per week.  
Demographics 
 There were some demographic differences in the three groups. There was a statistically 
significant difference in age (F(2) = 24.94, p < 0.05). The Tukey post hoc test revealed that 
participants were older in the ADHD/ADD No Stimulants group (M = 24 ± 6.59, p < 0.05) and 
in the ADHD/ADD Stimulants group (M = 23 ± 4.83, p < 0.05) as compared to the No 
ADHD/ADD group (M = 19.58 ± 1.53). There was a statistically significant difference of college 
year of participants between the 3 groups (F(2) = 8.77, p < 0.05). The Tukey post hoc test 
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revealed that participants had been in college longer in the ADHD/ADD Stimulants group (M = 
3.77 ± 1.74, p < 0.05) as compared to the No ADHD/ADD group (M = 2.17 ± 1.31). The Tukey 
test revealed that there was no difference of the college year of participants between the 
ADHD/ADD No Stimulants group and the other two groups. It could not be determined whether 
there was an association between group membership and gender or race of participants because 
the Chi-Square test could not be performed. The results of the Chi-Square test were invalid due 
to an insufficient distribution of participants that fit into each cell across the whole sample.   
Headache Experience 
 In contrast to our hypothesis regarding headache experience, the results did not show a 
significant difference in headache frequency, duration, or severity between those with 
ADHD/ADD who take stimulants and those with ADHD/ADD who do not take stimulants. In 
support of the hypothesis regarding headache experience, the results did not show a significant 
difference in headache frequency, duration, or severity between those with ADHD/ADD who do 
not take stimulants and those without ADHD/ADD who do not take stimulants. Headache 
frequency did not differ by group (F(2) = 0.41, p = 0.667). Headache duration also did not differ 
by group (F(2) = 0.62, p =0.542). The Chi-Square tests could not determine whether there was an 
association between group membership and headache severity due to an insufficient distribution 
of participants.  
Sleeping Habits 
 In contrast to our hypothesis regarding sleep habits, the results did not show a 
significant difference in sleep habits between those who take stimulants and those who do not 
take stimulants regardless of their ADHD/ADD diagnosis. In fact, no difference was observed 
HEADACHE, ADHD/ADD, AND STIMULANT MEDICATION 12 
 
between the three groups in terms of nightly hours of sleep (F(2) = 2.13, p = 0.122) or experience 
of sleepless nights (Chi-Square(2) = 0.415, p = 0.813). However, a difference was observed 
between the three groups regarding inconsistencies in bedtime (Chi-Square(2) = 6.302, p < 0.05) 
and waking time (Chi-Square(2) = 6.865, p< 0.05). Specifically, the results showed a 
relationship between having ADHD/ADD and having a more dysregulated waking and sleeping 
schedule. For bedtime inconsistency, the cell with the greatest contribution to the Chi-Square 
value was those from the ADHD/ADD No Stimulants group that have inconsistent bedtimes four 
or more times per week. The cell with the second greatest contribution to the Chi-Square value 
was those from the ADHD/ADD No Stimulants group that have inconsistent betimes less than 
four times per week. Of the 8 participants in the ADHD/ADD No Stimulants group, 7 reported 
having inconsistent bedtimes four or more times per week and 1 reported having inconsistent 
bedtimes less than four times per week. For waking time inconsistency by group was the cell 
with the greatest contribution to the Chi-Square value was those from the ADHD/ADD No 
Stimulants group that have inconsistent waking times four or more times per week. The cell with 
the second greatest contribution to the Chi-Square value was those from the ADHD/ADD No 
Stimulants group that have inconsistent waking times less than four times per week. Of the 8 
participants in the ADHD/ADD No Stimulants group, 6 reported having inconsistent waking 
times four or more times per week and 2 reported having inconsistent waking times less than 
four times per week.  
Eating Habits 
 In contrast to our hypothesis regarding eating habits, the results did not show a significant 
difference in eating habits between those who take stimulants and those who do not take 
stimulants regardless of their ADHD/ADD diagnosis. The Chi-Square test on weekly frequency 
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of skipping meals did not differ by group (Chi-Square(2) = 4.743, p = 0.093); however there was 
an observed trend towards an association between group and percentages of participants who 
skip meals at least four days per week versus those who skip meals less frequently across the 
three groups. The percentage of participants who skipped meals at least four days per week was 
69.23% of participants in the ADHD/ADD Stimulants group, 38.46% in the No ADHD/ADD 
group, and 37.5% in the ADHD/ADD No Stimulants group. 
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Discussion 
We initially intended to compare headache experience, in terms of frequency, duration, 
and severity of young adults with and without ADHD/ADD who do and do not take stimulants. 
The lack of participants without ADHD/ADD who take stimulants only allowed comparisons 
between three groups (No ADHD/ADD, ADHD/ADD No Stimulants, and ADHD/ADD 
Stimulants). We found no difference in headache experience when comparing the three groups. 
A prior study conducted by the K.G. Jebsen Centre for Research on Neuropsychiatric Disorders 
at the University of Bergen in Norway compared adult patients diagnosed with ADHD to 
community controls that responded to a survey asking about past and present symptoms of 
ADHD and migraine along with several other comorbid conditions (Fasmer 2011). The study 
found that adult patients with persistent ADHD had a higher prevalence of migraine than the 
control group (Fasmer 2011). The Neuropsychiatry Program at the University of Texas Health 
Science Center conducted a systematic review and meta-analysis of literature analyzing the 
association of ADHD with migraine and tension-type headache (Salem 2018). Their results 
showed a significant association between migraine and ADHD, however many of the studies that 
they analyzed did not look at migraine specifically, instead they investigated headache which 
does not have a clear association with ADHD (Salem 2018). Therefore, the results of our study 
were somewhat consistent with prior studies as we investigated headache in general—not 
migraine specifically—and found no significant difference in headache experience between those 
with and those without ADHD/ADD.  
Although, the three groups do not differ significantly in terms of headache experience, it 
is still important to understand if they differ significantly in lifestyle behavior to fully answer the 
question this study proposes. There could be significant differences in lifestyle behavior across 
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the three groups that although did not manifest into significant differences in headache 
experience, could have clinical value or inform further research. We examined whether lifestyle 
behaviors differed in those with and without ADHD/ADD. A significant difference in several 
sleep behaviors was shown. Specifically, those with ADHD/ADD had significantly more 
inconsistent bedtimes and waking times during a week than those without ADHD/ADD. A prior 
study conducted by the European Child & Adolescence Psychiatry found that sleep onset during 
weekdays was later and sleep duration was shorter in those with ADHD than those in the control 
group (van der Heijden 2018). While we found no significant difference in number of nightly 
hours of sleep, those with ADHD had a more inconsistent bedtime which is consistent with the 
results of a delayed sleep onset found in the European Psychiatry study (van der Heijden 2018). 
Our results showed no significant difference in the number of days per week that participants 
skipped meals between those with and without ADHD/ADD. No prior research has been 
conducted on skipping meals and ADHD.  
We examined whether taking stimulant drugs to treat ADHD/ADD could dysregulate 
one’s lifestyle. We observed that those with ADHD/ADD who do not take stimulants have a 
more inconsistent sleeping schedule that those with ADHD/ADD who take stimulants. Those 
with ADHD/ADD who take stimulants skipped meals more frequently than those with 
ADHD/ADD who do not take stimulants demonstrating a trend towards significance. No prior 
research was conducted specifically on the number of days participants skipped meals per week 
or consistency of sleep schedules in those with ADHD/ADD between those who take stimulants 
and those who do not. 
We proposed to examine whether having ADHD/ADD and taking stimulant drugs to treat 
it would dysregulate one’s lifestyle factors. We observed no significant difference in sleep or 
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eating habits between those with ADHD/ADD who take stimulant drugs to those who do not. No 
prior research was conducted on explicitly examining lifestyle factors of those with ADHD that 
take stimulants as compared to those without ADHD/ADD. 
The results of this study have some clinical relevance to practicing healthcare 
professionals as they provide some insight into the relationship between having ADHD/ADD 
and the dysregulation of some aspects of lifestyle behaviors. If the impact is significant enough, 
this could potentially lead to more frequent or worsened headache experience. Although the 
results showed no definitive relationship between headache experience and having ADHD/ADD 
or taking stimulants, the potential for a relationship is still possible and more research on the 
topic must be conducted. We sought to lay the foundation for more research to be conducted 
going forward and to highlight the lack of research conducted on this topic as a whole. Practicing 
clinicians, doctors, and nurses should routinely ask their patients with ADHD/ADD if they are 
experiencing headache or migraine and recommend that they monitor their experience. Likewise, 
healthcare professionals should routinely ask their patients with ADHD/ADD who take 
stimulants such as Adderall and Vyvanse about their eating habits and give them strategies to 
ensure that they are not frequently skipping meals. 
One of the study’s strengths is the research design. Using a cross-sectional approach that 
utilized an anonymous electron survey, we were able to collect data effectively and safely during 
a global pandemic. While our recruitment strategies were effective at generating a fair number of 
study participants as a whole, the number of participants in each group was unbalanced. Most 
notably, there was an insufficient number of participants without ADHD/ADD who took 
stimulants causing us to combine all participants without ADHD/ADD into one group. Although 
UConn is a great sample population for college-aged individuals in the U.S., it was not a great 
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university to investigate recreational Adderall and Vyvanse usage. As it turns out, recreational 
Adderall and Vyvanse usage appears to be less rampant across UConn’s campus as it has been 
reported across other college campuses in the U.S. Additionally, there was insufficient 
participation and variety of responses in some groups resulting in inconclusive Chi-Square tests 
on certain variables. Therefore, we were unable to examine whether a statistically significant 
difference was present between groups for several variables. This made analyzing and 
interpreting the data challenging. Future studies need to be conducted investigating this question 
on a much larger sample. Future research should be conducted on university campuses that have 
prevalent recreation stimulant drug usage. However, the challenge is in writing the survey 
questions in a way that makes participants feel comfortable reporting that they use stimulants 
recreationally since Adderall and Vyvanse are federally controlled substances and recreational 
usage of them is illegal.  
In summary, those with ADHD/ADD are significantly more likely to have a dysregulated 
sleep schedule and those with ADHD/ADD that take stimulants may show a pattern of skipping 
meals. The relationship between headache experience and ADHD/ADD diagnosis and stimulant 
drug usage while not significant is still unclear. Although a promising first step, future research 
is needed to further understand the relationships between ADHD/ADD diagnosis, stimulant drug 
usage, headache experience, and the dysregulation of one’s lifestyle behaviors.  
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